Trial intelligence / Profile preview

Magnetic Resonance Imaging of Aortic Aneurysm Instability

2008-001732-13Phase 2Completed

Sponsor
University of Edinburgh
Start
Jun 2008
Modality
Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of ferumoxtran-10 in abdominal aortic aneurysm (AAA), sponsored by University of Edinburgh. Primary endpoint: Change in relative signal intensity in aneurysm wall. Started Jun 2008; status: completed.

02

Drugs

ferumoxtran-10
03

Conditions

abdominal aortic aneurysm (AAA)

Beyond the preview

Go deeper on 2008-001732-13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-001732-13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call